Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin pre-emptive treatment vs placebo in high-risk surgical patients
2008-006409-18Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in invasive candidiasis and candidiasis comparing Micafungin with Placebo (2 arms). Primary endpoints: Incidence of invasive fungal infection at end of treatment, Incidence of invasive candidiasis at end of treatment and 1 more. Started Jan 2010; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasiscandidiasis
Beyond the preview
Go deeper on 2008-006409-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006409-18.